Molecular mechanisms of CD4+ T-cell anergy

Nature Reviews Immunology

Volumn 7, Issue 8, 2007, Pages 599-609

  Fathman, C Garrison ^a   Lineberry, Neil B ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CASITAS B LINEAGE LYMPHOMA B PROTEIN; CD3 ANTIGEN; CYCLOSPORIN A; CYTOKINE; DIACYLGLYCEROL; EARLY GROWTH RESPONSE FACTOR; GUANINE NUCLEOTIDE EXCHANGE FACTOR; IONOMYCIN; LAT PROTEIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PROTEIN; PROTEIN GRAIL; RAS GUANYL RELEASING PROTEIN 1; SUPERANTIGEN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; UBIQUITIN; UBIQUITIN BINDING PROTEIN; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ANTIGEN PRESENTING CELL; AUTOIMMUNE DISEASE; CALCIUM TRANSPORT; CD4+ T LYMPHOCYTE; CLONAL ANERGY; CYTOKINE PRODUCTION; ENZYME BINDING; HUMAN; IMMUNOLOGICAL TOLERANCE; LYMPHOCYTE PROLIFERATION; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN MODIFICATION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; UBIQUITINATION;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CLONAL ANERGY; HUMANS; LYMPHOCYTE ACTIVATION; PROTEOME; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES;

EID: 34547222902     PISSN: 14741733     EISSN: None     Source Type: Journal    
DOI: 10.1038/nri2131     Document Type: Review

References (105)

1. Kronenberg, M. & Rudensky, A. Regulation of immunity by self-reactive T cells. Nature 435, 598-604 (2005).
2. Rathmell, J. C. & Thompson, C. B. Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell 109, S97-S107 (2002).
3. Starr, T. K., Jameson, S. C. & Hogquist, K. A. Positive and negative selection of T cells. Annu. Rev. Immunol. 21, 139-176 (2003).
4. Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Quill, H. & Schwartz, R. H. T-cell unresponsiveness in vivo and in vitro: fine specificity of induction and molecular characterization of the unresponsive state. Immunol. Rev. 95, 113-135 (1987).
5. Schwartz, R. H. T cell anergy. Annu. Rev. Immunol. 21, 305-334 (2003). An outstanding in-depth review about the experiments used to originally identify and define both clonal T-cell anergy and adaptive tolerance.
6. Jenkins, M. K., Pardoll, D. M., Mizuguchi, J., Chused, T. M. & Schwartz, R. H. Molecular events in the induction of a nonresponsive state in interleukin 2-producing helper T-lymphocyte clones. Proc. Natl Acad. Sci. USA 84, 5409-5413 (1987).
7. Quill, H. & Schwartz, R. H. Stimulation of normal inducer T cell clones with antigen presented by purified Ia molecules in planar lipid membranes: specific induction of a long-lived state of proliferative nonresponsiveness. J. Immunol. 138, 3704-3712 (1987).
8. Jenkins, M. K., Chen, C. A., Jung, G., Mueller, D. L. & Schwartz, R. H. Inhibition of antigen-specific proliferation of type 1 murine T cell clones after stimulation with immobilized anti-CD3 monoclonal antibody. J. Immunol. 144, 16-22 (1990).
9. Hargreaves, R. G. et al. Dissociation of T cell anergy from apoptosis by blockade of Fas/Apo-1 (CD95) signaling. J. Immunol. 158, 3099-3107 (1997).
10. Beverly, B., Kang, S. M., Lenardo, M. J. & Schwartz, R. H. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4, 661-671 (1992).
11. Kang, S. M. et al. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257, 1134-1138 (1992).
12. + T cells. Science 271, 1276-1278 (1996).
13. + T cells. Science 271, 1272-1276 (1996).
14. DeSilva, D. R., Feeser, W. S., Tancula, E. J. & Scherle, P. A. Anergic T cells are defective in both jun NH2-terminal kinase and mitogen-activated protein kinase signaling pathways. J. Exp. Med. 183, 2017-2023 (1996).
15. Lyakh, L., Ghosh, P. & Rice, N. R. Expression of NFAT-family proteins in normal human T cells. Mol. Cell. Biol. 17, 2475-2484 (1997).
16. + T cells in vitro. Int. Immunol. 9, 935-944 (1997).
17. Hayashi, R. J., Loh, D. Y., Kanagawa, O. & Wang, F. Differences between responses of naive and activated T cells to anergy induction. J. Immunol. 160, 33-38 (1998).
18. Su, B. et al. JNK is involved in signal integration during costimulation of T lymphocytes. Cell 77, 727-736 (1994).
19. Telander, D. G., Malvey, E. N. & Mueller, D. L. Evidence for repression of IL-2 gene activation in anergic T cells. J. Immunol. 162, 1460-1465 (1999).
20. Ramsdell, F., Lantz, T. & Fowlkes, B. J. A nondeletional mechanism of thymic self tolerance. Science 246, 1038-1041 (1989).
21. + T cells by staphylococcal enterotoxin B. J. Exp. Med. 172, 1091-1100 (1990).
22. + T cells in Staphylococcus enterotoxin B-primed mice. J. Exp. Med. 172, 1065-1070 (1990).
23. + T cells persist in vivo following induction of peripheral tolerance. J. Immunol. 160, 4719-4729 (1998).
24. + T cells. J. Exp. Med. 185, 405-414 (1997).
25. Rocha, B., Tanchot, C. & Von Boehmer, H. Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J. Exp. Med. 177, 1517-1521 (1993).
26. Rocha, B., Grandien, A. & Freitas, A. A. Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J. Exp. Med. 181, 993-1003 (1995).
27. Frauwirth, K. A., Alegre, M. L. & Thompson, C. B. Induction of T cell anergy in the absence of CTLA-4/B7 interaction. J. Immunol. 164, 2987-2993 (2000).
28. Perez, V. L. et al. Induction of peripheral T cell tolerance in vivo requires CTLA-4 engagement. Immunity 6, 411-417 (1997).
29. Downward, J., Graves, J. D., Warne, P. H., Rayter, S. & Cantrell, D. A. Stimulation of p21ras upon T-cell activation. Nature 346, 719-723 (1990).
30. Izquierdo, M., Downward, J., Graves, J. D. & Cantrell, D. A. Role of protein kinase C in T-cell antigen receptor regulation of p21ras: evidence that two p21ras regulatory pathways coexist in T cells. Mol. Cell. Biol. 12, 3305-3312 (1992).
31. Cullen, P. J. & Lockyer, P. J. Integration of calcium and Ras signalling. Nature Rev. Mol. Cell Biol. 3, 339-348 (2002).
32. Ebinu, J. O. et al. RasGRP, a Ras guanyl nucleotide-releasing protein with calcium-and diacylglycerol-binding motifs. Science 280, 1082-1086 (1998).
33. Bivona, T. G. et al. Phospholipase C? activates Ras on the Golgi apparatus by means of RasGRP1. Nature 424, 694-698 (2003).
34. Ebinu, J. O. et al. RasGRP links T-cell receptor signaling to Ras. Blood 95, 3199-3203 (2000).
35. Dower, N. A. et al. RasGRP is essential for mouse thymocyte differentiation and TCR signaling. Nature Immunol. 1, 317-321 (2000).
36. Olenchock, B. A. et al. Disruption of diacylglycerol metabolism impairs the induction of T cell anergy. Nature Immunol. 7, 1174-1181 (2006).
37. Zha, Y. et al. T cell anergy is reversed by active Ras and is regulated by diacylglycerol kinase-α. Nature Immunol. 7, 1166-1173 (2006). References 36 and 37 describe the identification of attenuated DAG signalling due to its conversion to phosphatidic acid in multiple model systems of T-cell anergy.
38. Zhong, X. P. et al. Regulation of T cell receptor-induced activation of the Ras-ERK pathway by diacylglycerol kinase ζ. J. Biol. Chem. 277, 31089-31098 (2002).
39. Zhong, X. P. et al. Enhanced T cell responses due to diacylglycerol kinase ζ deficiency. Nature Immunol. 4, 882-890 (2003).
40. Macian, F. et al. Transcriptional mechanisms underlying lymphocyte tolerance. Cell 109, 719-731 (2002). This paper shows that the presence of NFAT in the nucleus, in the absence of the AP1 heterodimer, imparts an anergic gene-expression profile that is distinct from that seen during full T-cell activation.
41. 2+ signals without interfering with the induction of clonal anergy. Eur. J. Immunol. 32, 2500-2509 (2002).
42. Thiel, G. & Cibelli, G. Regulation of life and death by the zinc finger transcription factor Egr-1. J. Cell. Physiol. 193, 287-292 (2002).
43. + T cells. J. Immunol. 173, 7331-7338 (2004).
44. Safford, M. et al. Egr-2 and Egr-3 are negative regulators of T cell activation. Nature Immunol. 6, 472-480 (2005). This paper shows that EGR2 and EGR3 expression is associated with T-cell anergy and also contributes to T-cell anergy induction by upregulating the expression of CBL-B.
45. Houtman, J. C., Barda-Saad, M. & Samelson, L. E. Examining multiprotein signaling complexes from all angles. FEBS J. 272, 5426-5435 (2005).
46. Hundt, M. et al. Impaired activation and localization of LAT in anergic T cells as a consequence of a selective palmitoylation defect. Immunity 24, 513-522 (2006). This study shows attenuated LAT signalling due to altered palmitoylation and membrane relocalization in multiple systems of T-cell anergy.
47. Goldstein, G. et al. Isolation of a polypeptide that has lymphocyte-differentiating properties and is probably represented universally in living cells. Proc. Natl Acad. Sci. USA 72, 11-15 (1975).
48. Wilkinson, K. D., Urban, M. K. & Haas, A. L. Ubiquitin is the ATP-dependent proteolysis factor I of rabbit reticulocytes. J. Biol. Chem. 255, 7529-7532 (1980).
49. Pickart, C. M. & Fushman, D. Polyubiquitin chains: polymeric protein signals. Curr. Opin. Chem. Biol. 8, 610-616 (2004).
50. Tanaka, T., Soriano, M. A. & Grusby, M. J. SLIM is a nuclear ubiquitin E3 ligase that negatively regulates STAT signaling. Immunity 22, 729-736 (2005).
51. Liu, W. H. & Lai, M. Z. Deltex regulates T-cell activation by targeted degradation of active MEKK1. Mol. Cell. Biol. 25, 1367-1378 (2005).
52. Zhao, H. et al. A novel E3 ubiquitin ligase TRAC-1 positively regulates T cell activation. J. Immunol. 174, 5288-5297 (2005).
53. Vinuesa, C. G. et al. A RING-type ubiquitin ligase family member required to repress follicular helper T cells and autoimmunity. Nature 435, 452-458 (2005).
54. Heissmeyer, V. et al. Calcineurin imposes T cell unresponsiveness through targeted proteolysis of signaling proteins. Nature Immunol. 5, 255-265 (2004).
55. + T cells. Immunity 18, 535-547 (2003). References 54, 55 and 69 describe for the first time the role of the E3 ubiquitin ligases CBL-B, GRAIL and ITCH in the induction of T-cell anergy.
56. Mueller, D. L. E3 ubiquitin ligases as T cell anergy factors. Nature Immunol. 5, 883-890 (2004).
57. Keane, M. M., Rivero-Lezcano, O. M., Mitchell, J. A., Robbins, K. C. & Lipkowitz, S. Cloning and characterization of Cbl-b: a SH3 binding protein with homology to the c-Cbl proto-oncogene. Oncogene 10, 2367-2377 (1995).
58. Elly, C. et al. Tyrosine phosphorylation and complex formation of Cbl-b upon T cell receptor stimulation. Oncogene 18, 1147-1156 (1999).
59. Bachmaier, K. et al. Negative regulation of lymphocyte activation and autoimmunity by the molecular adaptor Cbl-b. Nature 403, 211-216 (2000).
60. Chiang, Y. J. et al. Cbl-b regulates the CD28 dependence of T-cell activation. Nature 403, 216-220 (2000).
61. Li, D. et al. Cutting edge: Cbl-b: one of the key molecules tuning CD28- and CTLA-4-mediated T cell costimulation. J. Immunol. 173, 7135-7139 (2004).
62. Zhang, J. et al. Cutting edge: regulation of T cell activation threshold by CD28 costimulation through targeting Cbl-b for ubiquitination. J. Immunol. 169, 2236-2240 (2002).
63. Bustelo, X. R., Crespo, P., Lopez-Barahona, M., Gutkind, J. S. & Barbacid, M. Cbl-b, a member of the Sli-1/c-Cbl protein family, inhibits Vav-mediated c-Jun N-terminal kinase activation. Oncogene 15, 2511-2520 (1997).
64. Krawczyk, C. et al. Cbl-b is a negative regulator of receptor clustering and raft aggregation in T cells. Immunity 13, 463-473 (2000).
65. Viola, A., Schroeder, S., Sakakibara, Y. & Lanzavecchia, A. T lymphocyte costimulation mediated by reorganization of membrane microdomains. Science 283, 680-682 (1999).
66. Fang, D. & Liu, Y. C. Proteolysis-independent regulation of PI3K by Cbl-b-mediated ubiquitination in T cells. Nature Immunol. 2, 870-875 (2001).
67. Fang, D. et al. Cbl-b, a RING-type E3 ubiquitin ligase, targets phosphatidylinositol 3-kinase for ubiquitination in T cells. J. Biol. Chem. 276, 4872-4878 (2001).
68. Han, J. et al. Role of substrates and products of PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav. Science 279, 558-560 (1998).
69. Jeon, M. S. et al. Essential role of the E3 ubiquitin ligase Cbl-b in T cell anergy induction. Immunity 21, 167-177 (2004).
70. Jun, J. E. & Goodnow, C. C. Scaffolding of antigen receptors for immunogenic versus tolerogenic signaling. Nature Immunol. 4, 1057-1064 (2003).
71. Cenciarelli, C. et al. Activation-induced ubiquitination of the T cell antigen receptor. Science 257, 795-797 (1992).
72. Hou, D., Cenciarelli, C., Jensen, J. P., Nguygen, H. B. & Weissman, A. M. Activation-dependent ubiquitination of a T cell antigen receptor subunit on multiple intracellular lysines. J. Biol. Chem. 269, 14244-14247 (1994).
73. Cenciarelli, C., Wilhelm, K. G. Jr, Guo, A. & Weissman, A. M. T cell antigen receptor ubiquitination is a consequence of receptor-mediated tyrosine kinase activation. J. Biol. Chem. 271, 8709-8713 (1996).
74. Schonrich, G. et al. Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction. Cell 65, 293-304 (1991).
75. Naramura, M., Kole, H. K., Hu, R. J. & Gu, H. Altered thymic positive selection and intracellular signals in Cbl-deficient mice. Proc. Natl Acad. Sci. USA 95, 15547-15552 (1998).
76. Thien, C. B. et al. Loss of c-Cbl RING finger function results in high-intensity TCR signaling and thymic deletion. EMBO J. 24, 3807-3819 (2005).
77. Naramura, M. et al. c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation. Nature Immunol. 3, 1192-1199 (2002).
78. + T cells by the Cbl family proteins. Immunity 25, 571-581 (2006).
79. Seroogy, C. M. et al. The gene related to anergy in lymphocytes, an E3 ubiquitin ligase, is necessary for anergy induction in CD4 T cells. J. Immunol. 173, 79-85 (2004).
80. Borchers, A. G. et al. The E3 ubiquitin ligase GREUL1 anteriorizes ectoderm during Xenopus development. Dev. Biol. 251, 395-408 (2002).
81. Soares, L. et al. Two isoforms of otubain 1 regulate T cell anergy via GRAIL. Nature Immunol. 5, 45-54 (2004).
82. Su, L., Lineberry, N., Huh, Y., Soares, L. & Fathman, C. G. A novel E3 ubiquitin ligase substrate screen identifies Rho guanine dissociation inhibitor as a substrate of gene related to anergy in lymphocytes. J. Immunol. 177, 7559-7566 (2006).
83. Schwartz, M. Rho signalling at a glance. J. Cell Sci. 117, 5457-5458 (2004).
84. 18H mice. Nature Genet. 18, 143-146 (1998).
85. Angers, A., Ramjaun, A. R. & McPherson, P. S. The HECT domain ligase itch ubiquitinates endophilin and localizes to the trans-Golgi network and endosomal system. J. Biol. Chem. 279, 11471-11479 (2004).
86. Mondino, A. et al. Defective transcription of the IL-2 gene is associated with impaired expression of c-Fos, FosB, and JunB in anergic T helper 1 cells. J. Immunol. 157, 2048-2057 (1996).
87. Fang, D. et al. Dysregulation of T lymphocyte function in itchy mice: a role for Itch in TH2 differentiation. Nature Immunol. 3, 281-287 (2002).
88. Gao, M. et al. Jun turnover is controlled through JNK-dependent phosphorylation of the E3 ligase Itch. Science 306, 271-275 (2004). This paper nicely shows how extracellular stimuli through the MAPK pathway regulate the turnover of the JUN family of transcription factors by ITCH.
89. Gallagher, E., Gao, M., Liu, Y. C. & Karin, M. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl Acad. Sci. USA 103, 1717-1722 (2006).
90. Yang, C. et al. Negative regulation of the E3 ubiquitin ligase itch via Fyn-mediated tyrosine phosphorylation. Mol. Cell 21, 135-141 (2006).
91. Fang, D. & Kerppola, T. K. Ubiquitin-mediated fluorescence complementation reveals that Jun ubiquitinated by Itch/AIP4 is localized to lysosomes. Proc. Natl Acad. Sci. USA 101, 14782-14787 (2004).
92. Venuprasad, K. et al. Convergence of Itch-induced ubiquitination with MEKK1-JNK signaling in Th2 tolerance and airway inflammation. J. Clin. Invest. 116, 1117-1126 (2006).
93. Harvey, K. F., Shearwin-Whyatt, L. M., Fotia, A., Parton, R. G. & Kumar, S. N4WBP5, a potential target for ubiquitination by the Nedd4 family of proteins, is a novel Golgi-associated protein. J. Biol. Chem. 277, 9307-9317 (2002).
94. Oliver, P. M. et al. Ndfip1 protein promotes the function of itch ubiquitin ligase to prevent T cell activation and T helper 2 cell-mediated inflammation. Immunity 25, 929-940 (2006).
95. Cristillo, A. D., Nie, L., Macri, M. J. & Bierer, B. E. Cloning and characterization of N4WBP5A, an inducible, cyclosporine-sensitive, Nedd4-binding protein in human T lymphocytes. J. Biol. Chem. 278, 34587-34597 (2003).
96. Magnifico, A. et al. WW domain HECT E3s target Cbl RING finger E3s for proteasomal degradation. J. Biol. Chem. 278, 43169-43177 (2003).
97. Mouchantaf, R. et al. The ubiquitin ligase itch is auto-ubiquitylated in vivo and in vitro but is protected from degradation by interacting with the deubiquitylating enzyme FAM/USP9X. J. Biol. Chem. 281, 38738-38747 (2006).
98. Hicke, L., Schubert, H. L. & Hill, C. P. Ubiquitin-binding domains. Nature Rev. Mol. Cell Biol. 6, 610-621 (2005).
99. Carpino, N. et al. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Immunity 20, 37-46 (2004).
100. Kowanetz, K. et al. Suppressors of T-cell receptor signaling Sts-1 and Sts-2 bind to Cbl and inhibit endocytosis of receptor tyrosine kinases. J. Biol. Chem. 279, 32786-32795 (2004).
101. Feshchenko, E. A. et al. TULA: an SH3- and UBA-containing protein that binds to c-Cbl and ubiquitin. Oncogene 23, 4690-4706 (2004).
102. Pickart, C. M. Mechanisms underlying ubiquitination. Annu. Rev. Biochem. 70, 503-533 (2001).
103. Nijman, S. M. et al. A genomic and functional inventory of deubiquitinating enzymes. Cell 123, 773-786 (2005).
104. Cadwell, K. & Coscoy, L. Ubiquitination on nonlysine residues by a viral E3 ubiquitin ligase. Science 309, 127-130 (2005).
105. Cambier, J. C., Gauld, S. B. Merrell, K. T. & Vilen, B. J. B-cell anergy: from transgenic models to naturally occurring anergic B cells? Nature Rev. Immunol. 7, 633-643 (2007).